Evaluating the performance characteristics of five lateral flow assays for the detection of the SARS-CoV-2 nucleocapsid antigen

In response to the COVID-19 pandemic, lateral flow assays (LFAs) for the detection of SARS-CoV-2 antigen have been proposed as a complementary option to the more costly and time consuming reverse-transcriptase polymerase chain reaction (RT-PCR). We assessed five commercially available SARS-CoV-2 ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Heskin, J., Pallett, S. J. C., Al-Hindawi, A., Davies, G. W., Rayment, M., Mughal, N., Randell, P., Jones, R., Moore, L. S. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130972/
https://www.ncbi.nlm.nih.gov/pubmed/35614181
http://dx.doi.org/10.1038/s41598-022-12805-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130972/
https://www.ncbi.nlm.nih.gov/pubmed/35614181
http://dx.doi.org/10.1038/s41598-022-12805-1

Ejemplares similares